BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/16/2018 5:25:43 PM | Browse: 563 | Download: 396
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
|
Manuscript Source |
Invited Manuscript |
All Author List |
Abdel-Rahman Zekri, Somaya El Deeb, Abeer Bahnassy, Abeer Badr, Mona S. Abdellateif, Gamal Esmat, Hosny Salama, Marwa Mohanad, Ahmed Esam El-dien, Shimaa Rabah and Assmaa Abd Elkader |
Funding Agency and Grant Number |
|
Corresponding Author |
Abdel-Rahman Zekri, MSc, PhD, Professor, Molecular Virology and Immunology Unit, Department of Cancer Biology, National Cancer Institute, Cairo University, Kasr Al-Aini Street, Fom El-Khaleeg, Cairo 11976, Egypt. ncizekri@yahoo.com |
Key Words |
Hepatocellular carcinoma; Hepatitis C virus; NKG2D; CD40; interleukin-2; interleukin-10; myeloid dendritic cells; plasmacytoid cells; natural killer cell; Cytokines |
Core Tip |
We assessed the levels of different immune modulatory cytokines and innate immune cells as natural killer (NK) cells and dendritic cells (DCs) in patients with disease progression of hepatocarcinogenesis. Our results showed significant down-regulation in active mDCs and pDCs expressing CD40 as well as NK cells expressing NKG2D. The expression of NKG2D on NKs was not expressed in 63% of hepatocellular carcinoma (HCC) patients. Also, there was significant decrease of interleukin (IL)-2, interferon-α and interferon-γ, and a significant increase in IL-10, IL-1β, and TNF-αR2 in HCC patients. These factors could be implicated in the pathogenesis of HCC, and represent attractive targets for therapy in chronic hepatitis C virus hepatitis and HCC. |
Citation |
Zekri AN, El Deeb S, Bahnassy AA, Badr AM, Abdellateif MS, Esmat G, Salama H, Mohanad M, El-dien AE, Rabah S, Abd Elkader A. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gastroenterol 2018; 24(11): 1228-1238 |
|
Received |
|
2017-11-05 17:02 |
|
Peer-Review Started |
|
2017-11-06 00:54 |
|
To Make the First Decision |
|
2017-11-22 01:08 |
|
Return for Revision |
|
2017-11-27 06:46 |
|
Revised |
|
2017-12-24 07:31 |
|
Second Decision |
|
2018-01-16 12:48 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-01-16 17:25 |
|
Articles in Press |
|
2018-01-16 17:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-01-27 20:14 |
|
Typeset the Manuscript |
|
2018-03-15 09:14 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345